MedPath

广东大翔制药有限公司

Ownership
-
Established
2011-03-08
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

46

NMPA:46

Drug Approvals

Compound Sodium Acetate Ringer’s Injection

Product Name
复方醋酸钠林格注射液
Approval Number
国药准字H20253990
Approval Date
Apr 22, 2025
NMPA

Compound Sodium Acetate Ringer’s Injection

Product Name
复方醋酸钠林格注射液
Approval Number
国药准字H20253991
Approval Date
Apr 22, 2025
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
左氧氟沙星氯化钠注射液
Approval Number
国药准字H20253439
Approval Date
Feb 20, 2025
NMPA

Levofloxacin and Sodium Chloride Injection

Product Name
左氧氟沙星氯化钠注射液
Approval Number
国药准字H20253438
Approval Date
Feb 20, 2025
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20227062
Approval Date
Apr 29, 2022
NMPA

Metronidazole and Sodium Chloride Injection

Product Name
甲硝唑氯化钠注射液
Approval Number
国药准字H20113496
Approval Date
Aug 26, 2020
NMPA

Levofloxacine Lactate and Sodium Chloride Injection

Product Name
乳酸左氧氟沙星氯化钠注射液
Approval Number
国药准字H20113295
Approval Date
Aug 4, 2020
NMPA

Glucose Injection

Product Name
葡萄糖注射液
Approval Number
国药准字H20204001
Approval Date
Jul 30, 2020
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20204002
Approval Date
Jul 30, 2020
NMPA

Dextran 20 and Sodium Chloride Injection

Product Name
右旋糖酐20氯化钠注射液
Approval Number
国药准字H14020773
Approval Date
Jun 12, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.